Announcement
From the Vitamin D Newsletter by Dr John Cannell, Vitamin D Council. Although the Vitamin D Council and I believe that vitamin D ought to be taken daily to mimic daily sun exposure, I understand the power and reasoning why some doctors prefer to write prescriptions at weekly, fortnightly or monthly directions. For one, it […]
Continue reading about Bio-Tech 50,000 IU D3 Now Available For Prescription
From Vitamin D Newsletter by Dr John Cannell, Vitamin D Council, 28 February 2012. Heart failure is a condition where the body can’t pump enough blood to meet the needs of its body. When we think of heart failure, we think of older persons whose heart has worn out, not 4-month-old infants. However, chronic congestive […]
Continue reading about Infant Heart Failure And Vitamin D Supplementation
FDA has approved important safety label changes for the class of cholesterol-lowering drugs known as statins. The changes include removal of routine monitoring of liver enzymes from drug labels. Information about the potential for generally non-serious and reversible cognitive side effects and reports of increased blood sugar and glycosylated hemoglobin (HbA1c) levels has been added […]
The March 2012 edition of The Health Gazette Ezine will be published as scheduled on March 1st. The March edition continues a brief series on aging. This month’s installment considers a simple definition of aging and briefly explores two theories of aging, one bio-physical and one psych-social. Subscribers will find the ezine in their mailbox […]
Continue reading about March 2012 Edition of The Health Gazette Ezine
The FDA is warning healthcare professionals and patients about a counterfeit version of Avastin 400mg/16mL, which may have been purchased and used by some medical practices in the United States. The counterfeit version is labeled as Avastin, manufactured by Roche and does not contain the medicine’s active ingredient, bevacizumab, which my have resulted in patients […]
Continue reading about FDA MedWatch – Avastin (bevacizumab): Counterfeit Product